Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial
| Image |  |
|---|---|
| Description | scientific article published on 11 December 2015 |
| Author/s |
author: Amalia Gastaldelli |
| Publication date | December 11, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |